Printer Friendly

Sweet route to heading off colon cancer.

In recent years, a host of studies have identified a broad spectrum of medical attributes in honey -- including antifungal, antibacterial, anti-inflammatory, antiproliferative, and cancer-drug-potentiating properties. Now, researchers at the American Health Foundation in Valhalla, N.Y., have uncovered another. In the Sept. 15 CANCER RESEARCH, Bandaru S. Reddy and his co-workers describe the ability of honey-derived caffeic esters to inhibit the development of precancerous changes in the colon of rats given a known carcinogen.

These esters come from the propolis -- the brown, resinous, tree-derived material that honeybees use to cement together their hives. Reddy's group considers three derivatives of the caffeic esters promising enough to use in longer-term animal studies of colon cancer.
COPYRIGHT 1993 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:honey-derived caffeic esters slow precancerous changes in rat colons
Publication:Science News
Article Type:Brief Article
Date:Sep 25, 1993
Previous Article:Reinventing the space station.
Next Article:Tamoxifen slashes serum cholesterol ... but shows link to 'bad' uterine cancers.

Related Articles
Aspirin slashes colon-cancer death rates.
Cancer protection from fruits and veggies.
Colon cancer away?
Can folic acid fight cancer?
Colon cancer treatment shows promise.
Tallying wheat bran's gutsy benefits.
Diabetes drug stirs cancer confusion.
Colonoscopy screening would avert cancer.
D-fending the colon: bile component triggers vitamin D receptor. (Science News This Week).
How to stop a silent killer: colorectal cancer screening. (On First Reading).

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters